Production (Stage)
Amicus Therapeutics, Inc.
FOLD
$6.22
-$0.04-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.69M | 14.74M | -6.73M | -15.70M | -48.42M |
| Total Depreciation and Amortization | 1.84M | 2.04M | 2.17M | 2.18M | 2.15M |
| Total Amortization of Deferred Charges | 606.00K | 597.00K | 574.00K | 560.00K | 531.00K |
| Total Other Non-Cash Items | 20.99M | 22.45M | 24.99M | 24.55M | 38.36M |
| Change in Net Operating Assets | 6.01M | -43.74M | -43.98M | 11.09M | -22.32M |
| Cash from Operations | 7.76M | -3.92M | -22.97M | 22.69M | -29.70M |
| Capital Expenditure | -212.00K | -288.00K | -356.00K | -1.10M | -1.81M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.65M | -20.10M | 34.63M | -20.88M | 9.35M |
| Cash from Investing | -32.86M | -20.39M | 34.27M | -21.98M | 7.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.00K | -43.00K | 24.00K | -36.00K | -42.00K |
| Issuance of Common Stock | 105.00K | 1.97M | 20.96M | 863.00K | 3.45M |
| Repurchase of Common Stock | -11.79M | -828.00K | -2.79M | -1.68M | -16.72M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.70M | 1.10M | 18.19M | -857.00K | -13.31M |
| Foreign Exchange rate Adjustments | 4.82M | 3.11M | -5.03M | -294.00K | -1.82M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.98M | -20.10M | 24.46M | -437.00K | -37.28M |